(Q33657656)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Development of a recombinant growth factor and fusion protein: lessons from GM-CSF (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

P J Morrissey

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Toxicologic Pathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

72-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10367677%20AND%20SRC:MED&resulttype=core&format=json

Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Clinical use of hematopoietic growth factors for control of infections after high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

M-CSF: haematopoietic growth factor or inflammatory cytokine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

In vitro production of megakaryocytes from PIXY321 versus GM-CSF-mobilized peripheral blood progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Animal models for the biological effects of continuous high cytokine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Hematopoietic growth factors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Cytokines in stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Clinical toxicity of cytokines used as haemopoietic growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114

Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339902700114